Researchers to Test Nicotine Patches on Coronavirus Patients after Study Suggests Lower Rates of Infection in Smokers

Researchers to Test Nicotine Patches on Coronavirus Patients after Study Suggests Lower Rates of Infection in Smokers

A French study found that only 4.4% of 350 coronavirus patients hospitalized were regular smokers while 5.3% of 130 released home smoked. Researchers in France are planning to test nicotine patches in coronavirus patients and healthcare workers to determine whether nicotine helps to prevent or lessen the effects of coronavirus.…
Allergan, Sightsavers & the IAPB Announce the ‘Keep Sight’ Initiative to Address Glaucoma in Odisha

Allergan, Sightsavers & the IAPB Announce the ‘Keep Sight’ Initiative to Address Glaucoma in Odisha

A unique initiative which joins an innovative eyecare biopharma leader with international charities to train healthcare professionals to diagnose and treat patients with glaucoma. Allergan, Sightsavers and the International Agency for the Prevention of Blindness (IAPB) have announced the launch of its unique joint initiative - ‘Keep Sight India’ – a community based glaucoma screening progamme to prevent glaucoma-related…
Takeda Pharmaceuticals Initiates Plasma-Derived Therapy for COVID-19

Takeda Pharmaceuticals Initiates Plasma-Derived Therapy for COVID-19

An anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) is being developed by the company to treat infected, high-risk individuals. Takeda Pharmaceutical Company Ltd. has said it will share with members of the United States Congress the development of an anti-SARS-CoV-2 polyclonal hyperimmune globulin (H-IG) to treat high-risk individuals with coronavirus outbreak, while…